A director at Prospect Capital Corp bought 319,000 shares at 3.162USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Two Directors at Verona Pharma sold 100,000 shares at 91.207USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Heartland Express, Inc. Declares Regular Quarterly Dividend NORTH LIBERTY, Iowa, June 13, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Heartland Express, Inc. (Nasdaq: HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on July 3, 2025, to shareholders of record at the close of business on June 23, 2025. We currently estimate that a total of $1.6 million will be paid on the Company's approximate seventy-eight million shares of common stock. This is the Company's eighty-eighth consecutive quarterly cash dividend. With ...
Prospect Capital Announces Special Meeting Update NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, "Company", “our”, or “we”) today announced that it held its special meeting of stockholders (the “Special Meeting”) on June 9, 2025. The proposals that were considered at the Special Meeting are described in detail in the Company’s definitive proxy statement for the Special Meeting as filed with the Securities and Exchange Commission on March 11, 2025 (the “Proxy”). As of March 11, 2025, there were 445,761,031 shares of the Company's common...
Verona Pharma Announces June 2025 Investor Conference Participation LONDON and RALEIGH, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will participate in fireside chats at the following conferences in June 2025: Jefferies Global Healthcare ConferenceDate: Wednesday, June 4, 2025Time: 11:05 a.m. ET / 4:05 p.m. BSTLocation: New York, NY Goldman Sachs 46th Annual Global Healthcare ConferenceDate: Monday, June 9, 2025Time: 2:40 p.m. ET / 7:40 p.m. BSTLocation: Miami, FL A webcast of each conferenc...
Prospect Capital Corporation Announces Redemption of its 3.706% Notes due 2026 NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect,” “our” or “we”) announced today that it will redeem all outstanding 3.706% Notes due 2026 (the “Notes”) at a price of 100% of the principal amount of the Notes to be redeemed, plus accrued but unpaid interest, to but excluding the Redemption Date (the “Redemption Price”). The redemption date will be June 18, 2025 (the “Redemption Date”). The Notes are held through The Depository Trust Company and will be redeemed...
A director at Heartland Express Inc maiden bought 2,000 shares at 8.760USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Prospect Capital Announces Financial Results for Fiscal March 2025 Quarter NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended March 31, 2025. FINANCIAL RESULTS All amounts in $000’s except per share amounts (on weighted average basis for period numbers)Quarter EndedMarch 31, 2025Quarter EndedDecember 31, 2024Quarter EndedMarch 31, 2024 Net Investment Income (“NII”)$83,489$86,431$94,375NII per Common Share$0.19$0.20$0.23Interest as % of Total Investment Income...
Prospect Capital Schedules Third Fiscal Quarter Earnings Release and Conference Call NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (the “Company” or “Prospect”) today announced it expects to file with the Securities and Exchange Commission its report on Form 10-Q containing results for the fiscal quarter ended March 31, 2025 on Thursday, May 8, 2025. The Company also expects to issue its earnings press release on Thursday, May 8, 2025, after the close of the markets. The Company will host a conference call on Friday, May 9, 2025 at 9:00 a.m. Easte...
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025 Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dualinhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces ten posters including seven additional analyses from its Phase 3 ENHANCE studies with Ohtuvayre (ensifentrine) for the treatment of chronic obstructive pulmonary disease (“COPD”),...
Heartland Express, Inc. Reports Operating Results for the First Quarter of 2025 NORTH LIBERTY, Iowa, April 30, 2025 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced today financial results for the three months ended March 31, 2025. Three months ended March 31, 2025: Operating Revenue of $219.4 million,Net Loss of $13.9 million, Basic Loss per Share of $0.18,Operating Ratio of 106.8% and 107.1% Non-GAAP Adjusted Operating Ratio(1),Total Assets of $1.3 billion, including $23.9 million of Cash,Stockholders' Equity of $807.7 million. Heartland Express ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.